(Phenylthio)acetyl chloride → HCID 66780119, compound

HRID 1958040Notes

Reaction equation

HRID 1958040 reaction equation
[Cl:1][C:2]1[C:3]([CH3:24])=[C:4]([CH2:8][NH:9][C:10]2[N:11]=[C:12]([N:18]3[CH2:23][CH2:22][O:21][CH2:20][CH2:19]3)[S:13][C:14]=2[C:15]([NH2:17])=[O:16])[CH:5]=[CH:6][CH:7]=1.[S:25]([CH2:32][C:33](Cl)=O)[C:26]1[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=1>O1CCCC1>[Cl:1][C:2]1[C:3]([CH3:24])=[C:4]([CH2:8][N:9]2[C:10]3[N:11]=[C:12]([N:18]4[CH2:19][CH2:20][O:21][CH2:22][CH2:23]4)[S:13][C:14]=3[C:15](=[O:16])[N:17]=[C:33]2[CH2:32][S:25][C:26]2[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=2)[CH:5]=[CH:6][CH:7]=1

Participants

4

Procedure

To a solution of 4-{[(3-chloro-2-methylphenyl)methyl]amino}-2-(4-morpholinyl)-1,3-thiazole-5-carboxamide (100 mg, 0.273 mmol) in Tetrahydrofuran (THF) (1363 μl) was added thiophenoxyacetyl chloride (102 mg, 0.545 mmol). The mixture was stirred at room temperature for 3 h, then irradiated (uwave) at 90° C. for 15 min. The mixture was quenched with methanol, concentrated, and purified by reversed-phase HPLC to provide 4-[(3-chloro-2-methylphenyl)methyl]-2-(4-morpholinyl)-5-[(phenylthio)methyl][1,3]thiazolo[4,5-d]pyrimidin-7(4H)-one. (20 mg, 15%); LC/MS: MS (ES+) m/e 499 (MH+); 1H NMR (400 MHz, DMSO-d6) δ ppm 2.36 (s, 3H), 3.52-3.59 (m, 4H), 3.62-3.73 (m, 4H), 4.18 (s, 2H), 5.59 (s, 2H), 6.52 (d, J=7.8 Hz, 1H), 7.15 (t, J=8.0 Hz, 1H), 7.21-7.42 (m, 6H).

Workup

  1. customirradiated (uwave) at 90° C. for 15 min
  2. customThe mixture was quenched with methanol
  3. concentrationconcentrated
  4. custompurified by reversed-phase HPLC

Sources & evidence

ORD record
ord-b94f3c211d2b444299c3d1eb637e2df2
Source dataset
uspto-grants-2013_04
Patent number
US08410095B2

Reaction notes

Loading…